Public private partnerships and emerging technologies: A look at nanomedicine for diseases of poverty

Research Policy

Volumn 45, Issue 7, 2016, Pages 1410-1418

  Woodson, Thomas S ^a  

^a Stony Brook University   (United States)

Author keywords

Diseases of poverty; Emerging technologies; Inclusive innovation; Nanotechnology; Public private partnership

Indexed keywords

MERGERS AND ACQUISITIONS; NANOTECHNOLOGY; PATENTS AND INVENTIONS; WEBSITES;

DEVELOPING PRODUCT; EMERGING TECHNOLOGIES; INCLUSIVE INNOVATIONS; NANOTECHNOLOGY RESEARCH; PUBLIC PRIVATE PARTNERSHIPS; REGULATION PROCESS; RESEARCH FUNDING; WEB SITE CONTENTS;

MEDICAL NANOTECHNOLOGY;

EID: 84992300451     PISSN: 00487333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.respol.2016.04.005     Document Type: Article

References (42)

1. Avila-Robinson, A., Miyazaki, K., 2011. Conceptualization and operationalization of emerging technologies: a complementing approach, in: Technology Management in the Energy Smart World (PICMET), 2011 Proceedings of PICMET'11: IEEEp. 1-12.
2. T. Bovaird Public-Private partnerships: from contested concepts to prevalent practice Int. Rev. Adm. Sci. 70 2004 199 215 10.1177/0020852304044250
3. D.W. Brinkerhoff, and J.M. Brinkerhoff Public-private partnerships: perspectices on purposes publicness, and good governance Publ. Adminstration Dev. 31 2011 2 14 10.1002/pad
4. J. Chataway, S. Brusoni, E. Cacciatori, R. Hanlin, and L. Orsenigo The international AIDS vaccine initiative (IAVI) in a changing landscape of vaccine development: a public/private partnership as knowledge broker and integrator Eur. J. Dev. Res. 19 2007 100 117 10.1080/09578810601144350
5. J. Chataway, R. Hanlin, L. Muraguri, and W. Wamae PDPs as social technology innovators in global health: operating above and below the radar Innovating for the Health of All 2009 Global Forum for Health Research Geneva, Switzerland
6. J. Chataway, R. Hanlin, J. Mugwagwa, and L. Muraguri Global health social technologies: reflections on evolving theories and landscapes Res. Policy 39 2010 1277 1288 10.1016/j.respol.2010.07.006
7. J. Cohen The new world of global health Science 80 311 2006 162 167
8. S.E. Cozzens, S. Gatchair, J. Kang, K.-S. Kim, H.J. Lee, G. Ordóñez, and A. Porter Emerging technologies: quantitative identification and measurement Technol. Anal. Strateg. Manag. 22 2010 361 376 10.1080/09537321003647396
9. G.S. Day, and P.J.H. Schoemaker Avoiding the pitfalls of emerging technologies Calif. Manage. Rev. 42 2000 8 33 10.2307/41166030
10. P. Evers Nanotechnology in Medical Applications. BCC Research Healthcare Report 2012 BCC Research Wellesley, MA
11. R.G.A. Feachem, and J.D. Sachs Global Public Goods for Health.Report of Working Group 2 of the Commission on Macroeconomics and Health 2002 World Health Organization Geneva
12. R.P. Feynman Plenty of room at the bottom APS Annual Meeting 1959
13. R.A. Freitas What is nanomedicine? Nanomed. Nanotechnol. Biol. Med. 1 2005 2 9 10.1016/j.nano.2004.11.003
14. R. Glennerster, M. Kremer, and H. Williams Creating markets for vaccines Innov. Technol. Gov. Global 1 2006 67 79 10.1162/itgg.2006.1.1.67
15. Global Forum for Health Research Equitable Access: Research Challenges for Health in Developing Countries 2007 Pro-Book Publishing London
16. C. Grace Product Development Partnerships (PDPs): Lessons from PDPs Established to Develop New Health Technologies for Neglected Diseases 2010 Human Development Resource Centre, Department for International Development UK, London
17. C. Greve Public-private partnerships: a public policy perspective G.A. Hodge, Privatization and Market Development: Global Movements in Public Policy Ideas 2006 Edward Elgar Cheltenham 63 77
18. S.C. Herring Web content analysis: expanding the paradigm J. Hunsinger, L. Klastrup, M.M. Allen, International Handbook of Internet Research 2010 Springer Netherlands 233 249
19. N. Invernizzi Nanomedicineoverty and development Development 49 2006 114
20. M. Kremer Pharmaceuticals and the developing world J. Econ. Perspect. 16 2002 67 90
21. D.C. Maclurcan Nanotechnology and the Hope for a More Equitable World: A Mixed Methods Study 2010 University of Technology Sydney
22. S.J. McMillan The microscope and the moving target: the challenge of applying content analysis to the world wide web J. Mass Commun. Q. 77 2000
23. R.W. McQuaid The theory of partnerships - why have partnerships Managing Public-Private Partnerships for Public Services: An International Perspective 2000 pp. 9-35
24. F. Miraftab Public-private partnerships: the trojan horse of neoliberal development? J. Plan. Educ. Res. 24 2004 89 101
25. M. Moran, J. Guzman, A.L. Ropars, and A. Illmer The role of product development partnerships in research and development for neglected diseases Int. Health 2 2010 114 122 10.1016/j.inhe.2010.04.002
26. M. Moran A breakthrough in R&D for neglected diseases: new ways to get the drugs we need PLoS Med. 2 2005 e302 10.1371/journal.pmed.0020302
27. V. Munoz, F. Visentin, D. Foray, and P. Gaule Can medical products be developed on a non-profit basis? Exploring product development partnerships for neglected diseases Sci. Public Policy 42 2015 1 24 10.1093/scipol/scu049
28. C.J.L. Murray, T. Vos, R. Lozano, M. Naghavi, A.D. Flaxman, C. Michaud, M. Ezzati, K. Shibuya, J.A. Salomon, S. Abdalla, V. Aboyans, J. Abraham, I. Ackerman, R. Aggarwal, S.Y. Ahn, M.K. Ali, M.A. Almazroa, M. Alvarado, H.R. Anderson, L.M. Anderson, K.G. Andrews, C. Atkinson, L.M. Baddour, A.N. Bahalim, S. Barker-collo, L.H. Barrero, D.H. Bartels, M. Basáñez, A. Baxter, M.L. Bell, E.J. Benjamin, D. Bennett, E. Bernabé, K. Bhalla, B. Bhandari, B. Bikbov, A. Abdulhak, G. Bin Birbeck, J.A. Black, H. Blencowe, J.D. Blore, F. Blyth, I. Bolliger, A. Bonaventure, S. Boufous, R. Bourne, M. Boussinesq, T. Braithwaite, C. Brayne, L. Bridgett, S. Brooker, P. Brooks, T.S. Brugha, C. Bryan-hancock, C. Bucello, R. Buchbinder, G. Buckle, C.M. Budke, M. Burch, P. Burney, R. Burstein, B. Calabria, B. Campbell, C.E. Canter, H. Carabin, J. Carapetis, L. Carmona, C. Cella, M.D. Connor, L.T. Cooper, M. Corriere, M. Cortinovis, K.C. Vaccaro, W. De Couser, B.C. Cowie, M.H. Criqui, M. Cross, K.C. Dabhadkar, M. Dahiya, N. Dahodwala, J. Damsere-derry, G. Danaei, A. Davis, D. Leo, L. De Degenhardt, R. Dellavalle, A. Delossantos, J. Denenberg, S. Derrett, D.C. Jarlais Des, S.D. Dharmaratne, M. Dherani, C. Diaz-torne, H. Dolk, E.R. Dorsey, T. Driscoll, H. Duber, B. Ebel, K. Edmond, A. Elbaz, S.E. Ali, H. Erskine, P.J. Erwin, P. Espindola, S.E. Ewoigbokhan, F. Farzadfar, F.G.R. Fowkes, M. Fransen, M.K. Freeman, B.J. Gabbe, S.E. Gabriel, E. Gakidou, H.A. Ganatra, B. Garcia, F. Gaspari, R.F. Gillum, G. Gmel, D. Gonzalez-medina, R. Gosselin, R. Grainger, B. Grant, J. Groeger, F. Guillemin, D. Gunnell, R. Gupta, J. Haagsma, H. Hagan, Y.A. Halasa, W. Hall, D. Haring, J.M. Haro, J.E. Harrison, R. Havmoeller, R.J. Hay, H. Higashi, C. Hill, B. Hoen, H. Hoff, P.J. Hotez, D. Hoy, J.J. Huang, S.E. Ibeanusi, K.H. Jacobsen, S.L. James, J. Khoo, C.H. King, L.M. Knowlton, O. Kobusingye, A. Koranteng, R. Krishnamurthi, F. Laden, R. Lalloo, L.L. Laslett, T. Lathlean, J.L. Leasher, Y.Y. Lee, J. Leigh, D. Levinson, S.S. Lim, E. Limb, J.K. Lin, M. Lipnick, S.E. Lipshultz, W. Liu, M. Loane, J. Mcgrath, M.E. Medina-mora, M. Meltzer, Z.A. Memish, G.A. Mensah, T.R. Merriman, A. Meyer, V. Miglioli, M. Miller, T.R. Miller, P.B. Mitchell, C. Mock, A.O. Mocumbi, T.E. Moffi, A.A. Mokdad, L. Monasta, M. Montico, M. Moradi-lakeh, A. Moran, M.C. Nevitt, C.R. Newton, S. Nolte, P. Norman, R. Norman, M.O. Donnell, S.O. Hanlon, C. Olives, S.B. Omer, K. Ortblad, F. Perez-ruiz, N. Perico, K. Pesudovs, D. Phillips, M.R. Phillips, K. Pierce, S. Pion, G.V. Polanczyk, S. Polinder, J. Singleton, D.A. Sleet, K. Sliwa, E. Smith, J.L. Smith, N.J.C. Stapelberg, A. Steer, T. Steiner, W.A. Stolk, L.J. Stovner, C. Sudfeld, S. Syed, G. Tamburlini, M. Tavakkoli, H.R. Taylor, J.A. Taylor, W.J. Taylor, B. Thomas, W.M. Thomson, E. Witt, F. Wolfe, A.D. Woolf, S. Wulf, P. Yeh, A.K.M. Zaidi, Z. Zheng, D. Zonies, and A.D. Lopez Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010 Lancet 380 2012 10.1016/S0140-6736(12)61689-4
29. National Science and Technology Council, 2011. National Nanotechnology Initiative: Strategic Plan. Washington, D.C.
30. D. Rotolo, D. Hicks, and B.R. Martin What is an emerging technology? Res. Policy 2015 10.1016/j.respol.2015.06.006
31. A. Sosnik, and M. Amiji Nanotechnology solutions for infectious diseases in developing nations Adv. Drug Deliv. Rev. 62 2010 375 377 10.1016/j.addr.2009.11.010
32. The Economist Give, and it shall be given unto you Economist 2013 1 2
33. United States National Nanotechnology Initiative 2015 Nano [WWW Document]. URL http://www.nano.gov/ (accessed 8.31.15)
34. C. Weare, and W.-Y. Lin Content analysis of the world wide web: opportunities and challenges Soc. Sci. Comput. Rev. 18 2000 272 292 10.1177/089443930001800304
35. D. Webber, and M. Kremer Perspectives on stimulating industrial research and development for neglected infectious diseases Bull. World Health Organ. 79 2001 735 741
36. R. Wettenhall The public-private interface: surveying the history G.A. Hodge, C. Greve, The Challenge of Public-Private Partnerships: Learning from International Experience 2005 Edward Elgar Cheltenham 22 43
37. R. Widdus Public-private partnerships for health: their main targets, their diversity, and their future directions Bull. World Health Organ. 79 2001 713 720
38. E. Woodhouse, and D. Sarewitz Science policies for reducing societal inequities Sci. Public Policy 34 2007 139 150
39. T.S. Woodson Research inequality in nanomedicine J. Bus. Chem. 9 2012 133 146
40. World Health Organization TDR at a Glance 2010 World Health Organization Geneva, Switzerland
41. H. Van Ham, and J. Koppenjan Building Public-Private Partnerships: assessing and managing risks in port development Public Manage. Rev. 3 2001 593 616
42. P. von Philipsborn, F. Steinbeis, M.E. Bender, and P. Tinnemann Poverty-related and neglected diseases: an economic and epidemiological data analysis of poverty relatedness and neglect in research and development Glob. Health Action 382 2015 7 10.1016/S0140-6736(13)62168-6